IBDEI03C ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2983,1,4,0)
 ;;=4^Z71.0
 ;;^UTILITY(U,$J,358.3,2983,2)
 ;;=^5063242
 ;;^UTILITY(U,$J,358.3,2984,0)
 ;;=Z71.3^^20^213^12
 ;;^UTILITY(U,$J,358.3,2984,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2984,1,3,0)
 ;;=3^Dietary Counseling/Surveillance
 ;;^UTILITY(U,$J,358.3,2984,1,4,0)
 ;;=4^Z71.3
 ;;^UTILITY(U,$J,358.3,2984,2)
 ;;=^5063245
 ;;^UTILITY(U,$J,358.3,2985,0)
 ;;=Z71.41^^20^213^5
 ;;^UTILITY(U,$J,358.3,2985,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2985,1,3,0)
 ;;=3^Alcohol Abuse Counseling/Surveillance of Alcoholic
 ;;^UTILITY(U,$J,358.3,2985,1,4,0)
 ;;=4^Z71.41
 ;;^UTILITY(U,$J,358.3,2985,2)
 ;;=^5063246
 ;;^UTILITY(U,$J,358.3,2986,0)
 ;;=Z09.^^20^213^17
 ;;^UTILITY(U,$J,358.3,2986,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2986,1,3,0)
 ;;=3^F/U Exam After Trtmt for Cond Oth Than Malig Neop
 ;;^UTILITY(U,$J,358.3,2986,1,4,0)
 ;;=4^Z09.
 ;;^UTILITY(U,$J,358.3,2986,2)
 ;;=^5062668
 ;;^UTILITY(U,$J,358.3,2987,0)
 ;;=Z76.0^^20^213^23
 ;;^UTILITY(U,$J,358.3,2987,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2987,1,3,0)
 ;;=3^Issue of Repeat Prescription
 ;;^UTILITY(U,$J,358.3,2987,1,4,0)
 ;;=4^Z76.0
 ;;^UTILITY(U,$J,358.3,2987,2)
 ;;=^5063297
 ;;^UTILITY(U,$J,358.3,2988,0)
 ;;=Z04.8^^20^213^16
 ;;^UTILITY(U,$J,358.3,2988,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2988,1,3,0)
 ;;=3^Examination/Observation for Other Reasons
 ;;^UTILITY(U,$J,358.3,2988,1,4,0)
 ;;=4^Z04.8
 ;;^UTILITY(U,$J,358.3,2988,2)
 ;;=^5062665
 ;;^UTILITY(U,$J,358.3,2989,0)
 ;;=N39.0^^20^213^36
 ;;^UTILITY(U,$J,358.3,2989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2989,1,3,0)
 ;;=3^UTI
 ;;^UTILITY(U,$J,358.3,2989,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,2989,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,2990,0)
 ;;=B19.20^^20^213^22
 ;;^UTILITY(U,$J,358.3,2990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2990,1,3,0)
 ;;=3^Hepatitis C,Viral
 ;;^UTILITY(U,$J,358.3,2990,1,4,0)
 ;;=4^B19.20
 ;;^UTILITY(U,$J,358.3,2990,2)
 ;;=^331436
 ;;^UTILITY(U,$J,358.3,2991,0)
 ;;=B20.^^20^213^19
 ;;^UTILITY(U,$J,358.3,2991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2991,1,3,0)
 ;;=3^HIV
 ;;^UTILITY(U,$J,358.3,2991,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,2991,2)
 ;;=^5000555
 ;;^UTILITY(U,$J,358.3,2992,0)
 ;;=G35.^^20^213^31
 ;;^UTILITY(U,$J,358.3,2992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2992,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,2992,1,4,0)
 ;;=4^G35.
 ;;^UTILITY(U,$J,358.3,2992,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,2993,0)
 ;;=D68.311^^20^213^21
 ;;^UTILITY(U,$J,358.3,2993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2993,1,3,0)
 ;;=3^Hemophilia,Acquired
 ;;^UTILITY(U,$J,358.3,2993,1,4,0)
 ;;=4^D68.311
 ;;^UTILITY(U,$J,358.3,2993,2)
 ;;=^340502
 ;;^UTILITY(U,$J,358.3,2994,0)
 ;;=D68.312^^20^213^10
 ;;^UTILITY(U,$J,358.3,2994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2994,1,3,0)
 ;;=3^Antiphospholipid Antibody w/ Hemorrhagic Disorder
 ;;^UTILITY(U,$J,358.3,2994,1,4,0)
 ;;=4^D68.312
 ;;^UTILITY(U,$J,358.3,2994,2)
 ;;=^340503
 ;;^UTILITY(U,$J,358.3,2995,0)
 ;;=Z51.81^^20^213^35
 ;;^UTILITY(U,$J,358.3,2995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2995,1,3,0)
 ;;=3^Therapeutic Drug Level Monitoring
 ;;^UTILITY(U,$J,358.3,2995,1,4,0)
 ;;=4^Z51.81
 ;;^UTILITY(U,$J,358.3,2995,2)
 ;;=^5063064
 ;;^UTILITY(U,$J,358.3,2996,0)
 ;;=L03.90^^20^213^11
 ;;^UTILITY(U,$J,358.3,2996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2996,1,3,0)
 ;;=3^Cellulitis,Unspec
 ;;^UTILITY(U,$J,358.3,2996,1,4,0)
 ;;=4^L03.90
 ;;^UTILITY(U,$J,358.3,2996,2)
 ;;=^5009067
 ;;^UTILITY(U,$J,358.3,2997,0)
 ;;=99456^^21^214^2
 ;;^UTILITY(U,$J,358.3,2997,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2997,1,1,0)
 ;;=1^C&P F-T-F Visit
 ;;^UTILITY(U,$J,358.3,2997,1,2,0)
 ;;=2^99456
 ;;^UTILITY(U,$J,358.3,2998,0)
 ;;=99456^^21^214^4
 ;;^UTILITY(U,$J,358.3,2998,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2998,1,1,0)
 ;;=1^C&P Telehealth Visit
 ;;^UTILITY(U,$J,358.3,2998,1,2,0)
 ;;=2^99456
 ;;^UTILITY(U,$J,358.3,2999,0)
 ;;=99241^^21^214^5
 ;;^UTILITY(U,$J,358.3,2999,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,2999,1,1,0)
 ;;=1^C&P ACE Chart Review
 ;;^UTILITY(U,$J,358.3,2999,1,2,0)
 ;;=2^99241
 ;;^UTILITY(U,$J,358.3,3000,0)
 ;;=99456^^21^214^6
 ;;^UTILITY(U,$J,358.3,3000,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,3000,1,1,0)
 ;;=1^IDES F-T-F Visit
 ;;^UTILITY(U,$J,358.3,3000,1,2,0)
 ;;=2^99456
 ;;^UTILITY(U,$J,358.3,3001,0)
 ;;=99456^^21^214^7
 ;;^UTILITY(U,$J,358.3,3001,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,3001,1,1,0)
 ;;=1^IDES Telehealth Visit
 ;;^UTILITY(U,$J,358.3,3001,1,2,0)
 ;;=2^99456
 ;;^UTILITY(U,$J,358.3,3002,0)
 ;;=99456^^21^215^1
 ;;^UTILITY(U,$J,358.3,3002,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,3002,1,1,0)
 ;;=1^C&P F-T-F Visit
 ;;^UTILITY(U,$J,358.3,3002,1,2,0)
 ;;=2^99456
 ;;^UTILITY(U,$J,358.3,3003,0)
 ;;=99456^^21^215^2
 ;;^UTILITY(U,$J,358.3,3003,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,3003,1,1,0)
 ;;=1^C&P Telehealth Visit
 ;;^UTILITY(U,$J,358.3,3003,1,2,0)
 ;;=2^99456
 ;;^UTILITY(U,$J,358.3,3004,0)
 ;;=99241^^21^215^3
 ;;^UTILITY(U,$J,358.3,3004,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,3004,1,1,0)
 ;;=1^C&P ACE Chart Review
 ;;^UTILITY(U,$J,358.3,3004,1,2,0)
 ;;=2^99241
 ;;^UTILITY(U,$J,358.3,3005,0)
 ;;=99456^^21^215^4
 ;;^UTILITY(U,$J,358.3,3005,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,3005,1,1,0)
 ;;=1^IDES F-T-F Visit
 ;;^UTILITY(U,$J,358.3,3005,1,2,0)
 ;;=2^99456
 ;;^UTILITY(U,$J,358.3,3006,0)
 ;;=99456^^21^215^5
 ;;^UTILITY(U,$J,358.3,3006,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,3006,1,1,0)
 ;;=1^IDES Telehealth Visit
 ;;^UTILITY(U,$J,358.3,3006,1,2,0)
 ;;=2^99456
 ;;^UTILITY(U,$J,358.3,3007,0)
 ;;=99456^^21^216^1
 ;;^UTILITY(U,$J,358.3,3007,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,3007,1,1,0)
 ;;=1^C&P F-T-F Visit
 ;;^UTILITY(U,$J,358.3,3007,1,2,0)
 ;;=2^99456
 ;;^UTILITY(U,$J,358.3,3008,0)
 ;;=99456^^21^216^2
 ;;^UTILITY(U,$J,358.3,3008,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,3008,1,1,0)
 ;;=1^C&P Telehealth Visit
 ;;^UTILITY(U,$J,358.3,3008,1,2,0)
 ;;=2^99456
 ;;^UTILITY(U,$J,358.3,3009,0)
 ;;=99456^^21^216^3
 ;;^UTILITY(U,$J,358.3,3009,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,3009,1,1,0)
 ;;=1^IDES F-T-F Visit
 ;;^UTILITY(U,$J,358.3,3009,1,2,0)
 ;;=2^99456
 ;;^UTILITY(U,$J,358.3,3010,0)
 ;;=99456^^21^216^4
 ;;^UTILITY(U,$J,358.3,3010,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,3010,1,1,0)
 ;;=1^IDES Telehealth Visit
 ;;^UTILITY(U,$J,358.3,3010,1,2,0)
 ;;=2^99456
 ;;^UTILITY(U,$J,358.3,3011,0)
 ;;=99456^^21^217^1
 ;;^UTILITY(U,$J,358.3,3011,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,3011,1,1,0)
 ;;=1^Face to Face SHA Exam
 ;;^UTILITY(U,$J,358.3,3011,1,2,0)
 ;;=2^99456
 ;;^UTILITY(U,$J,358.3,3012,0)
 ;;=99456^^21^218^1
 ;;^UTILITY(U,$J,358.3,3012,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,3012,1,1,0)
 ;;=1^C&P F-T-F Visit
 ;;^UTILITY(U,$J,358.3,3012,1,2,0)
 ;;=2^99456
 ;;^UTILITY(U,$J,358.3,3013,0)
 ;;=99456^^21^218^2
 ;;^UTILITY(U,$J,358.3,3013,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,3013,1,1,0)
 ;;=1^C&P Telehealth Visit
 ;;^UTILITY(U,$J,358.3,3013,1,2,0)
 ;;=2^99456
 ;;^UTILITY(U,$J,358.3,3014,0)
 ;;=99241^^21^218^3
 ;;^UTILITY(U,$J,358.3,3014,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,3014,1,1,0)
 ;;=1^C&P ACE Chart Review
 ;;^UTILITY(U,$J,358.3,3014,1,2,0)
 ;;=2^99241
 ;;^UTILITY(U,$J,358.3,3015,0)
 ;;=99456^^21^218^4
 ;;^UTILITY(U,$J,358.3,3015,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,3015,1,1,0)
 ;;=1^IDES F-T-F Visit
 ;;^UTILITY(U,$J,358.3,3015,1,2,0)
 ;;=2^99456
 ;;^UTILITY(U,$J,358.3,3016,0)
 ;;=99456^^21^218^5
 ;;^UTILITY(U,$J,358.3,3016,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,3016,1,1,0)
 ;;=1^IDES Telehealth Visit
 ;;^UTILITY(U,$J,358.3,3016,1,2,0)
 ;;=2^99456
 ;;^UTILITY(U,$J,358.3,3017,0)
 ;;=99450^^21^219^1
